Skip to Main Content

Paper Details

Second-Generation HSP90 Inhibitor Onalespib Blocks mRNA Splicing of Androgen Receptor Variant 7 in Prostate Cancer Cells.
Cancer Res
74
2016
Author NameAffiliation
Roberta FerraldeschiDivision of Clinical Studies and Cancer Therapeutics, The Institute of Cancer Research, Royal Marsden NHS Foundation Trust
Wei YuanDivision of Clinical Studies and Cancer Therapeutics, The Institute of Cancer Research
Susana MirandaDivision of Clinical Studies and Cancer Therapeutics, The Institute of Cancer Research
Suzanne CarreiraDivision of Clinical Studies and Cancer Therapeutics, The Institute of Cancer Research
Stephen R PlymateUniversity of Washington School of Medicine and GRECC at VAPSHCS Seattle
Gerhardt AttardDivision of Clinical Studies and Cancer Therapeutics, The Institute of Cancer Research, Royal Marsden NHS Foundation Trust
Paul WorkmanDivision of Clinical Studies and Cancer Therapeutics, The Institute of Cancer Research
Johann S de BonoDivision of Clinical Studies and Cancer Therapeutics, The Institute of Cancer Research, Royal Marsden NHS Foundation Trust
  • 1 - 8

Datasets